The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review

Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glyce...

Full description

Saved in:
Bibliographic Details
Main Authors: Chen-Ning Wu, Kai-Jen Tien
Format: Article
Language:English
Published: Wiley 2020-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2020/9368583
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832554598792953856
author Chen-Ning Wu
Kai-Jen Tien
author_facet Chen-Ning Wu
Kai-Jen Tien
author_sort Chen-Ning Wu
collection DOAJ
description Sarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glycemic control. Additionally, antidiabetic agents may alter the balance between protein synthesis and degradation through various mechanisms of skeletal muscle mass regulation. This study reviewed the literature on the pathogenesis of sarcopenia in diabetes mellitus and the current understanding of whether antidiabetic agents contribute positively or negatively to sarcopenia and muscle wasting.
format Article
id doaj-art-de4253addb8b4e5495471e4e11779b7e
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2020-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-de4253addb8b4e5495471e4e11779b7e2025-02-03T05:51:14ZengWileyJournal of Diabetes Research2314-67452314-67532020-01-01202010.1155/2020/93685839368583The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature ReviewChen-Ning Wu0Kai-Jen Tien1Department of Internal Medicine, Chi Mei Medical Center, Tainan, TaiwanDivision of Endocrinology and Metabolism, Department of Internal Medicine, Chi Mei Medical Center, Tainan, TaiwanSarcopenia is a geriatric syndrome characterized by decline of skeletal muscle mass and function. Contributing factors include nutritional, genetic, inflammatory, and endocrinal factors. The reported prevalence of sarcopenia in type 2 diabetes mellitus is high, especially in patients with poor glycemic control. Additionally, antidiabetic agents may alter the balance between protein synthesis and degradation through various mechanisms of skeletal muscle mass regulation. This study reviewed the literature on the pathogenesis of sarcopenia in diabetes mellitus and the current understanding of whether antidiabetic agents contribute positively or negatively to sarcopenia and muscle wasting.http://dx.doi.org/10.1155/2020/9368583
spellingShingle Chen-Ning Wu
Kai-Jen Tien
The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
Journal of Diabetes Research
title The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
title_full The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
title_fullStr The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
title_full_unstemmed The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
title_short The Impact of Antidiabetic Agents on Sarcopenia in Type 2 Diabetes: A Literature Review
title_sort impact of antidiabetic agents on sarcopenia in type 2 diabetes a literature review
url http://dx.doi.org/10.1155/2020/9368583
work_keys_str_mv AT chenningwu theimpactofantidiabeticagentsonsarcopeniaintype2diabetesaliteraturereview
AT kaijentien theimpactofantidiabeticagentsonsarcopeniaintype2diabetesaliteraturereview
AT chenningwu impactofantidiabeticagentsonsarcopeniaintype2diabetesaliteraturereview
AT kaijentien impactofantidiabeticagentsonsarcopeniaintype2diabetesaliteraturereview